Skip to main content
Have a personal or library account? Click to login
The prevalence of ER-low-positive breast cancer and its relation to tumor characteristics in Syria Cover

The prevalence of ER-low-positive breast cancer and its relation to tumor characteristics in Syria

Forum of Clinical Oncology
Volume 14 (2023): Issue 3 (December 2023)
By: Remal Abdulaziz Asaad,  Hla Sudan,  Bailasan Hasan and  Siraj Saadaldin Abdullah  
Open Access
|Sep 2024
Authors

Authors

Remal Abdulaziz Asaad

rimalasaad@tishreen.edu.sy

Clinical Biochemistry, Department of Biochemistry and Microbiology, Faculty of Pharmacy, Tishreen University, Latakia, Syria

Hla Sudan

Master in Laboratory Diagnosis, Department of Biochemistry and Microbiology, Faculty of Pharmacy, Tishreen University, Latakia, Syria

Bailasan Hasan

Master in Laboratory Diagnosis, Department of Biochemistry and Microbiology, Faculty of Pharmacy, Tishreen University, Latakia, Syria

Siraj Saadaldin Abdullah

Department of Surgery, National Hospital of Jableh, Latakia, Syria
DOI: https://doi.org/10.2478/fco-2023-0028 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 56 - 62
Submitted on: Jan 20, 2024
Accepted on: May 21, 2024
Published on: Sep 28, 2024
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
breast cancer,
ER-low-positive breast cancer,
CRP,
lymph node ratio—LNR,
invasive ductal carcinoma—IDC
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2024 Remal Abdulaziz Asaad, Hla Sudan, Bailasan Hasan, Siraj Saadaldin Abdullah, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 14 (2023): Issue 3 (December 2023)
Previous article
Next article